Award
NIH Reporter #5K43TW012801-03
Informing optimal dosing of the future antimalarial, artemether-lumefantrine plus amodiaquine, in key neglected target populations of children with severe acute malnutrition and adults living with HIV
Recipient
Kamuzu University of Health Sciences
Award Amount
$108,662.00
Ceiling
$108,662.00
Awarded
August 14, 2026
Identifier
5K43TW012801-03
The project will generate evidence to guide safe and effective dosing of the antimalarial combination ALAQ in children with severe acute malnutrition and adults living with HIV, with the goal of informing dosing guidance and helping address antimalarial drug resistance.
Description
Research project studying the safety, pharmacokinetic profiles, and optimal dosing of artemether-lumefantrine plus amodiaquine in children with severe acute malnutrition and adults living with HIV.